Sami et al. studied the effects of valproic acid on cervical cancer models, which elevated the expression of p21 and histone H3 acetylation, had a direct anti-angiogenic effect, as well as inhibited tumor growth, and improved survival advantages in vivo [82]. This evidence concerns the gene CDKN1A and cervical carcinoma.